InvestorsHub Logo
icon url

bandit0916

05/21/14 3:14 PM

#7794 RE: cptjsd #7792

I agree completely with what you say. If anyone expected ground breaking news and a huge price jump today they are fooling themselves. Titan has a timeline and they are sticking to it and until the FDA approves them we are sitting right here where we are at. And that is fine with me so I an buy more shares
icon url

Honeycomb777

05/21/14 3:14 PM

#7795 RE: cptjsd #7792

WOWEEE - We'll get taken out at $3.75 !!! I'll be able to afford pepperoni on my pizza. Folks - you are missing the big picture. Inaction and poor timing WILL affect future PPS.

John is doing a masterful job with getting his J&J cronies setup for a "sweetheart" deal
icon url

jetuomi

05/21/14 3:47 PM

#7817 RE: cptjsd #7792

I agree with your statement, I took away a lot of notes, and here are a couple of the "carrots" I left with;

- 30 months of funding
- 1 year away from trials
- 40 employees at ximedica working on this product
- 20 + medical experts say the video is better than state of art
- John currently talking about partnerships/sales in Europe
- CFO - $650k monthly burn rate
- CFO - Upto $80MM in Warrant funding to fund sales and post commercialization.

My opinions:

1) 50 million warrants though could dilute and not cause PPS appreciation like we expect
2) Mgmt is now less focused on PPS and more focused on product (I'm okay with this)
3) No Reverse Split (they didn't know what it was or why they would do it) - also no thinking currently of Nasdaq uplift.

Overall I would call this a Hold/Buy, as in, hold and buy more on dips. I can see this being a $800MM dollar company next year at the same time, and with say 120mm shares outstanding, that's about $6-$7 per share.